These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro. Hostanska K, Hajto T, Fischer J, Mengs U, Weber K, Lentzen H, Saller R. Cancer Detect Prev; 1999 Jan; 23(6):511-23. PubMed ID: 10571662 [Abstract] [Full Text] [Related]
3. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Hostanska K, Hajto T, Weber K, Fischer J, Lentzen H, Sütterlin B, Saller R. Nat Immun; 1999 Jan; 15(6):295-311. PubMed ID: 9523281 [Abstract] [Full Text] [Related]
4. [Mistletoe therapy from the pharmacologic perspective]. Hajto T, Hostanska K, Saller R. Forsch Komplementarmed; 1999 Aug; 6(4):186-94. PubMed ID: 10529578 [Abstract] [Full Text] [Related]
5. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R. Nat Immun; 1998 Aug; 16(1):34-46. PubMed ID: 9789123 [Abstract] [Full Text] [Related]
6. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration. Kunze E, Schulz H, Gabius HJ. J Cancer Res Clin Oncol; 1998 Aug; 124(2):73-87. PubMed ID: 9654190 [Abstract] [Full Text] [Related]
7. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I. Edlund U, Hensel A, Fröse D, Pfüller U, Scheffler A. Arzneimittelforschung; 2000 Jul; 50(7):645-51. PubMed ID: 10965423 [Abstract] [Full Text] [Related]
8. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response. Kunze E, Schulz H, Adamek M, Gabius HJ. J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906 [Abstract] [Full Text] [Related]
9. Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. Lavastre V, Pelletier M, Saller R, Hostanska K, Girard D. J Immunol; 2002 Feb 01; 168(3):1419-27. PubMed ID: 11801684 [Abstract] [Full Text] [Related]
10. Galactoside-specific plant lectin, Viscum album agglutinin-I induces enhanced proliferation and apoptosis of murine thymocytes in vivo. Hajtó T, Berki T, Boldizsár F, Németh P. Immunol Lett; 2003 Mar 03; 86(1):23-7. PubMed ID: 12600741 [Abstract] [Full Text] [Related]
11. Activation of human neutrophils by the plant lectin Viscum album agglutinin-I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis. Savoie A, Lavastre V, Pelletier M, Hajto T, Hostanska K, Girard D. J Leukoc Biol; 2000 Dec 03; 68(6):845-53. PubMed ID: 11129652 [Abstract] [Full Text] [Related]
12. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Ribéreau-Gayon G, Jung ML, Frantz M, Anton R. Anticancer Drugs; 1997 Apr 03; 8 Suppl 1():S3-8. PubMed ID: 9179359 [Abstract] [Full Text] [Related]
13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec 03; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
14. Anti-inflammatory effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammation in vivo. Lavastre V, Cavalli H, Ratthe C, Girard D. Clin Exp Immunol; 2004 Aug 03; 137(2):272-8. PubMed ID: 15270843 [Abstract] [Full Text] [Related]
15. Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance? Fritz P, Seizer-Schmidt R, Mürdter TE, Kroemer HK, Aulitzky W, André S, Gabius HJ, Friedel G, Toomes H, Siegle I. Acta Histochem; 1999 Jul 03; 101(3):239-53. PubMed ID: 10443287 [Abstract] [Full Text] [Related]
16. Impact of mistletoe lectin binding in breast cancer. Fritz P, Dippon J, Kierschke T, Siegle I, Möhring A, Moisa A, Mürdter TE. Anticancer Res; 2004 Jul 03; 24(2C):1187-92. PubMed ID: 15154645 [Abstract] [Full Text] [Related]
17. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Gabius HJ, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R. Cancer Invest; 2001 Jul 03; 19(2):114-26. PubMed ID: 11296616 [Abstract] [Full Text] [Related]
18. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G. In Vivo; 1993 Jul 03; 7(5):407-10. PubMed ID: 8110981 [Abstract] [Full Text] [Related]
19. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius HJ. J Mol Recognit; 1997 Jul 03; 10(3):139-47. PubMed ID: 9408830 [Abstract] [Full Text] [Related]
20. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Exp Hematol; 1997 Oct 03; 25(11):1125-39. PubMed ID: 9328449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]